午夜一级毛片-手机看片99-动漫人物桶机免费动漫app-日日摸日日碰夜夜97|www.zyjlr.com

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Guangdong reported 24 provinces in the drug price, your data has been checked!
 
Author:中國銘鉉 企劃部  Release Time:2016-12-15 8:29:32  Number Browse:808
 

Medical network on December 14th - prices start streaking! Drug firms before the price is no longer a secret!

On December 13, drug trading center of guangdong province issued "on the public medical institutions in guangdong province pharmaceutical trading data notice, 24 provinces were collected for drug purchase price, to the public. The public time on December 13, 2016 - December 20.

Notice, according to the published data is collected, anhui, fujian, gansu, guangxi, guizhou, hainan, henan, hubei, jilin, jiangsu, jiangxi, liaoning, Inner Mongolia, ningxia, qinghai, shaanxi, sichuan, shandong, Shanghai, tianjin, xinjiang, yunnan, zhejiang and Beijing 24 provinces (autonomous regions and municipalities directly under the central government) as of May 31, 2016 drug centralized purchasing prices are being executed, and drugs into the current market price data of guangdong province.

Such as enterprise to object to the published data, guangdong pharmaceutical trading center to give a chance to appeal (see attachment).

Shortly after, the Beijing drug action do require companies to provide various provinces in platform account, password, in order to real price; While jiangsu breath unveiled a enterprise self-reporting 18000 drugs in the province of "lowest price"; In addition, the national drug supply security integrated management information platform is now with the provincial bidding data connectivity. In such a transparent background, drug companies would also like to make different price has no meaning as usual, on the contrary also faces the risk of being punished.

So to speak, the price is transparent, through reference and comparison between provinces, a drug in each local prices tend to be unified, so, in the province of bidding for the unit, it seems meaning less. In addition, in order to "hook" quantity and price, the price of indiscriminate are carried out to unify, also seems to be inappropriate.

Attached: data sources to inform about the public medical institutions in guangdong province and drug business

The relevant enterprises:

According to the nine departments such as health and family planning commission of guangdong province about relevant interim measures issued by the guangdong province medical institutions and drug trading notice (yue who [2016] 2016 date) regulation, according to a new drug online trading work deployment, the provincial drug centralized purchasing system reform working group studies agree, will now medical institutions and drug trade into the market price of related data of guangdong province announces that the instructions are as follows:

A, the scope of the public

Collected in the published data sources for anhui, fujian, gansu, guangxi, guizhou, hainan, henan, hubei, jilin, jiangsu, jiangxi, liaoning, Inner Mongolia, ningxia, qinghai, shaanxi, sichuan, shandong, Shanghai, tianjin, xinjiang, yunnan, zhejiang and Beijing 24 provinces (autonomous regions and municipalities directly under the central government) as of May 31, 2016 drug centralized purchasing prices are being executed, and drugs into the current market price data of guangdong province.

Second, the publication time

On December 13, 2016 - December 20.

Third, viewing

Using data certificate login drug trading system, through the "information bulletin and" complaint management - data source of the public project "view.

Four, "(cast)

Such as enterprise to object to the published data, please enter the trading platform, each related enterprise corresponding product gauge click [new appeal] to fill in a complaint, submit audit after print attachment and fill in according to requirements of the form "(cast) v. materials (content should be consistent with online complaints), in the public deadline on December 19, 2016 by company authorized person before 17:00 PM will hold id original completed" (cast) v. materials (see attachment) submitted to drug trading center in guangdong province.

Five, the other instructions

(a) the above 24 provinces (autonomous regions and municipalities directly under the central government) -- as well as the data source of hunan province by the provincial health and family planning commission is responsible for collecting, data is not collected in other provinces.

(2) in acquisition of liaoning province data source of cheap drugs screening is commonly used in purchasing tables do not have a unified price unit (2014) data, and to the province medical institutions to bargain the price, than the bidding price; Collection of all data sources for purchasing the unit price of hunan province. Of the provincial task force meeting decided that a new round of trading into market prices do not use cheap drugs in liaoning province the net purchase table (2014) data source and all the data sources in hunan province.

(3) the appeal of incorrect data must be in the collection period, and enterprises are required to submit their incorrect data province (autonomous region or municipality directly under the central government) where the drug centralized purchasing management institutions or agencies to issue the correct original material, no documents to prove the complaint will not be processed.

Six, contact information

Submitted address: in yuexiu district of guangzhou city ring road east overseas Chinese saemaul undong guangming road 28 3 a building;

Tel: 4000-16-9191;

Guangdong pharmaceutical trading center website online customer service.

 
Previous article:A clinical pathway for seven years local hospital "soft landing" in place
Next article:The gaqsiq shall send warning: import medical instrument can't do it
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網安備 44011202000029號